about
Inflammatory bowel disease: A descriptive study of 716 local Chilean patientsTransition to adulthood of adolescents with inflammatory bowel diseaseGenetic Diversity and Virulence Determinants of Escherichia coli Strains Isolated from Patients with Crohn's Disease in Spain and Chile.Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.Metalloproteinase-dependent TLR2 ectodomain shedding is involved in soluble toll-like receptor 2 (sTLR2) production.Soluble ST2: a new and promising activity marker in ulcerative colitis.[Fecal microbiota transplantation: first case report in Chile and review].CON: surveillance for ulcerative colitis-associated cancer: time to change the endoscopy and the microscopy.Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolutionA functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitisHelicobacter pylori cagA+ Is Associated with Milder Duodenal Histological Changes in Chilean Celiac Patients.[Acute small bowel diverticulitis in a patient with crohn s disease].[Diverticular disease: myths and realities].[Chilean consensus of prevention, diagnosis and treatment of Clostridium difficile-associated diarrhea].[Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case].Corrigendum: Helicobacter pylori cagA+ Is Associated with Milder Duodenal Histological Changes in Chilean Celiac Patients.Constant TCR triggering suggests that the TCR expressed on intestinal intraepithelial γδ T cells is functional in vivo.Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology.Ionizing radiation exposure in patients with inflammatory bowel disease: are we overexposing our patients?Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection.Stem Cell Therapy in Refractory Perineal Crohn's Disease: Long-term Follow-up.Assessment of disease-related knowledge and possible factors associated with the knowledge level among Chilean patients with inflammatory bowel disease.Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.[Acute severe ulcerative colitis treated with accelerated infliximab induction. Case report].[Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].Low Gene Dosage of Cdc42 Is Not Associated with Protein Dysfunction in Patients with Colorectal Cancer.Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.[Rectal diffuse large B cell lymphoma appearing after immunosuppression for ulcerative colitis. Report of one case].[Benign multicystic peritoneal mesothelioma in a patient with Crohn disease].[Towards an integral management of inflammatory bowel disease].[Results or pelvi-perineal rehabilitation in patients with pelvic floor dyssynergia].Thromboembolism--an important manifestation of inflammatory bowel disease.Glucocorticoids Impair Phagocytosis and Inflammatory Response Against Crohn's Disease-Associated Adherent-Invasive Escherichia coli.Dendritic cells and toll-like receptors 2 and 4 in the ileum of Crohn's disease patientsCharacterization of the novel ST2/IL-33 system in patients with inflammatory bowel diseaseSurveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?Increased production of soluble TLR2 by lamina propria mononuclear cells from ulcerative colitis patients[Differences by age in clinical features of inflammatory bowel disease][Inflammatory bowel disease. Experience in 316 patients][Adverse events associated with the treatment of inflammatory bowel disease]
P50
Q24658457-429EF687-D74B-4C99-A157-DC9DF6857CE2Q26800948-7F92CFAD-3DC3-4EE3-AB67-D976E1D79AC3Q30352386-C51E6C09-4E6F-4B83-BDDC-2E73CB0A3427Q33821118-41745591-B3AD-4A8A-8E46-308EB78FF70DQ34756662-568B94A2-B010-417B-B281-75ABB3A0A620Q34975712-495F78FB-BBD1-4A8F-A0BE-D36F220570C1Q35345722-BB07F4B5-4618-4394-A978-FF9DECC61C69Q35872037-DDAA3CF4-A19C-4861-961B-A4B870139165Q36114510-8C40E7F3-9DBC-4343-ADE9-A67AE26F5340Q38599081-85D61C78-5EF8-46C6-B873-82324D3E563DQ40063198-E0C9A571-1318-4E69-8948-9EC3F5126412Q40197539-E0FE15E2-168B-4477-866D-236FA2A9C8AFQ40233775-663ADD99-7248-40CE-BFAA-1CFB600CC83BQ40759749-61F15BFC-A137-48BB-AD56-EB29D7C660E5Q41093013-DA4F9781-918A-4BBE-947F-F77360E13EDBQ42370024-56CBEEB8-FAD5-442C-847A-B26B9C4AF35EQ42480340-123CE1AD-55F6-432F-8A26-41FE5FC6CBFCQ42695145-A17C3451-39C7-449D-9A6C-A19947DD5478Q44262408-FC011C6B-724B-4880-97F3-435E512A0809Q46976190-255733FE-7115-479A-B02D-6926811BBDE2Q47189302-88D5B6C9-9216-4C3E-BF2A-8F6413811962Q47720147-7A7886FC-0394-4AEE-A05B-D5828DA49454Q48287325-065AD8AA-EFBA-4211-AFCF-02E2B2D37545Q49491071-592F8AD4-CAF5-4C0B-986E-A414E091477FQ50102348-03302419-F3C1-47E8-A9F7-DCE94141AC3BQ51562553-EBEEEBF8-CD51-4B1A-AF53-4463C81AE44CQ51752564-716D6487-9320-4323-B4BC-52CE9BE7B1F0Q52681911-A79DACB5-314F-4CE0-AF0B-EF174285FADEQ52685506-F2E99B44-DFE1-4348-B3DB-43245F5C6167Q52998090-C6FA3B13-0A7B-4C4F-AE76-0C59E5C8D631Q54593246-97F8E813-835F-49B6-99CE-0CA8482C58F4Q55039194-DC49B4BB-4DED-4251-BACA-0DB7748D98ABQ55354007-89D45AE9-0773-4F71-9614-3615E9F950D6Q80199820-8DA6A9DC-7371-4520-A8BD-BFBBCD5E0F51Q82257596-C1C328CB-38B3-4AF7-BD26-12A1419DC10CQ82556460-3EA45552-4DAF-4B1F-9F55-EFD29B8C2849Q82598944-6BADF6B5-7D7E-4368-8BA6-5C056F3B207FQ85686797-121E38B1-766E-422C-A4C2-F2543D306C57Q86055440-E16E408B-4D01-420F-9812-F40B9F5F92FDQ87090230-AA5B92F9-ACEE-4501-9B3E-0A8B75C416BA
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rodrigo Quera
@ast
Rodrigo Quera
@en
Rodrigo Quera
@es
Rodrigo Quera
@nl
type
label
Rodrigo Quera
@ast
Rodrigo Quera
@en
Rodrigo Quera
@es
Rodrigo Quera
@nl
prefLabel
Rodrigo Quera
@ast
Rodrigo Quera
@en
Rodrigo Quera
@es
Rodrigo Quera
@nl
P106
P1153
6602260152
P31
P496
0000-0001-5854-0526